Dr. MichaelBartosch

Partner

Munich + 49.89.20.60.42.303

Connect:

Share

Dr. Michael Bartosch has broad experience in assisting clients in cross-border and domestic M&A, private equity, venture capital, joint ventures, carve-outs and other corporate transactions, as well as corporate reorganizations and general corporate law matters. Many clients rely on him as their trusted advisor, and throughout his 15 years of practice, he has represented numerous strategic and financial investors in various industries, including automotive, manufacturing, technology, pharmaceuticals, and medical devices.

Prior to joining Jones Day in 2023, Michael was a partner in the Munich office of a U.S. law firm, where he represented a number of notable companies, including a large medical device company in the carve-out of its German business; BITZER, a leading manufacturer of refrigeration and air conditioning products, on the acquisition of OJ Electronics Group; Kamax, a prominent manufacturer for the automotive industry, on the acquisition of a majority stake in Galol Group; Evonik on the carve-out and sale of its methacrylates business to Advent International; TA Associates (TA), a leading global growth private equity firm, on the acquisition of a majority stake in Germany-based IGEL Group; and B.C. Jindal Group on the acquisition of Treofan Group, a former Celanese subsidiary from Italian private equity investor M&C S.p.A.

Michael is a member of the Rechtsanwaltskammer München (Munich Bar) and the German Bar Association.

Experience

  • Charge Construct sold to ace GroupJones Day advised the shareholders of Charge Construct GmbH on the sale of their shares to the newly formed ace Group, which is part of the portfolio of EMERAM Capital Partners.
  • TotalEnergies acquires Quadra EnergyJones Day advised TotalEnergies SE in the acquisition of Quadra Energy GmbH.
  • BITZER acquires BPOWERJones Day is advising BITZER in the acquisition of BPOWER, a.s., an engineering company supplying to the market turnkey power stations including Organic Rankine Cycle (ORC) systems.

    • The following represents experience acquired prior to joining Jones Day.

    Advised Evonik on the carve-out and sale of its methacrylates business to Advent International.

    Advised B.C. Jindal Group on the acquisition of Treofan Group.

    Advised TA Associates on the acquisition of a majority stake in IGEL Technology Group.

    Advised Celanese on the acquisition of the mobility and materials business of DuPont.

    Advised BITZER on various M&A transactions, including a joint venture with Wurm Group.

    Advised BOYD Corporation on the acquisition of Siltec Group.

    Advised KAMAX on the acquisition of Galol Group.

    Advised a global company active in the defense industry on the sale of its German defense business to a U.S. investor.

    Advised Johnson Controls on the spin-off of its global automotive seating business to Adient.

    Advised Cleverciti Systems on the growth capital financing by a syndicate including ENBW and The Westly Group.

    Advised a private equity fund on the acquisition of a life science company.

    Advised Reactive Robotics on various financing rounds.

    Advised Knorr Bremse on the acquisition of PCS Power Converter Solutions.

    Advised MAHLE on its participation in Behr.

    View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.